首页> 美国卫生研究院文献>Cancer Biotherapy Radiopharmaceuticals >Comparison of Cell-Labeling Methods with 124I-FIAU and 64Cu-PTSM for Cell Tracking Using Chronic Myelogenous Leukemia Cells Expressing HSV1-tk and Firefly Luciferase
【2h】

Comparison of Cell-Labeling Methods with 124I-FIAU and 64Cu-PTSM for Cell Tracking Using Chronic Myelogenous Leukemia Cells Expressing HSV1-tk and Firefly Luciferase

机译:比较使用124I-FIAU和64Cu-PTSM的细胞标记方法用于追踪表达HSV1-tk和萤火虫荧光素酶的慢性粒细胞白血病细胞的细胞标记方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell-tracking methods with molecular-imaging modality can monitor the biodistribution of cells. In this study, the direct-labeling method with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (64Cu-PTSM), indirect cell-labeling methods with herpes simplex virus type 1-thymidine kinase (HSV1-tk)-mediated 124I-2′-fluoro-2′-deoxy-1-β-d-arabinofuranosyl-5-iodouracil (124I-FIAU) were comparatively investigated in vitro and in vivo for tracking of human chronic myelogenous leukemia cells. K562-TL was established by retroviral transduction of the HSV1-tk and firefly luciferase gene in the K562 cell. K562-TL cells were labeled with 64Cu-PTSM or 124I-FIAU. Cell labeling efficiency, viability, and radiolabels retention were compared in vitro. The biodistribution of radiolabeled K562-TL cells with each radiolabel and small-animal positron emission tomography imaging were performed. Additionally, in vivo and ex vivo bioluminescence imaging (BLI) and tissue reverse transcriptase–polymerase chain reaction (RT-PCR) analysis were used for confirming those results. K562-TL cells were efficiently labeled with both radiolabels. The radiolabel retention (%) of 124I-FIAU (95.2%±1.1%) was fourfold higher than 64Cu-PTSM (23.6%±0.7%) at 24 hours postlabeling. Viability of radiolabeled cells was statistically nonsignificant between 124I-FIAU and 64Cu-PTSM. The radioactivity of each radiolabeled cells was predominantly accumulated in the lungs and liver at 2 hours. Both the radioactivity of 64Cu-PTSM- and 124I-FIAU-labeled cells was highly accumulated in the liver at 24 hours. However, the radioactivity of 124I-FIAU-labeled cells was markedly decreased from the body at 24 hours. The K562-TL cells were dominantly localized in the lungs and liver, which also verified by BLI and RT-PCR analysis at 2 and 24 hours postinjection. The 64Cu-PTSM-labeled cell-tracking method is more efficient than 124I-FIAU-labeled cell tracking, because of markedly decrease of radioactivity and fast efflux of 124I-FIAU in vivo. In spite of a high labeling yield and radiolabel retention of 124I-FIAU in vitro, the in vivo cell-tracking method using 64Cu-PTSM could be a useful method to evaluate the distribution and targeting of various cell types, especially, stem cells and immune cells.
机译:具有分子成像方式的细胞跟踪方法可以监测细胞的生物分布。在这项研究中,直接标记 64 Cu-丙酮醛-双(N4-甲基硫代半碳酰胺)( 64 Cu-PTSM)的方法,间接细胞标记方法为单纯疱疹病毒类型1-胸苷激酶(HSV1-tk)介导的 124 I-2'-氟-2'-脱氧-1-β-d-阿拉伯呋喃糖基-5-碘尿嘧啶( 124 <在体外和体内比较研究了追踪人慢性骨髓性白血病细胞的能力。通过逆转录病毒转导HSV1-tk和萤火虫荧光素酶基因在K562细胞中建立K562-TL。用 64 Cu-PTSM或 124 I-FIAU标记K562-TL细胞。在体外比较了细胞标记效率,活力和放射性标记保留。进行了每个放射性标记和小动物正电子发射断层显像的放射性标记K562-TL细胞的生物分布。此外,使用体内和体外生物发光成像(BLI)和组织逆转录酶-聚合酶链反应(RT-PCR)分析来确认这些结果。两种放射性标记均有效标记了K562-TL细胞。在24小时时, 124 I-FIAU(95.2%±1.1%)的放射性标记保留率(%)比 64 Cu-PTSM(23.6%±0.7%)高四倍后贴标签。在 124 I-FIAU和 64 Cu-PTSM之间,放射性标记细胞的活力在统计学上无统计学意义。在2小时时,每个放射性标记的细胞的放射性主要积累在肺和肝中。在24小时时, 64 Cu-PTSM-和 124 I-FIAU标记的细胞的放射性都高度积累。然而, 124 I-FIAU标记的细胞的放射性在24小时时显着降低。 K562-TL细胞主要位于肺和肝脏中,这也可以在注射后2和24小时通过BLI和RT-PCR分析进行验证。 64 Cu-PTSM标记的细胞跟踪方法比 124 I-FIAU标记的细胞跟踪方法更有效,因为放射性显着降低,的快速流出体内> 124 I-FIAU。尽管 124 I-FIAU具有较高的标记产率和放射性标记保留,但使用 64 Cu-PTSM进行的体内细胞跟踪方法可能是一种有用的方法评估各种细胞类型(尤其是干细胞和免疫细胞)的分布和靶向性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号